MTNB · Matinas BioPharma Holdings, Inc.
$0.18
+0.00 (+0.55%)
At close · Sep 4
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company does not believe that the cash and cash equivalents on hand are sufficient to fund planned operations for a period of at least twelve months from the filing date of these financial statements. As a result, substantial doubt exists about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$2.67M
Shares
14.69M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Jerome D. Jabbour | Chief Executive Officer | $598,000 |
| Jerome Jabbour | CEO | $598,000 |
| James Ferguson | Former Chief Medical Officer | $589,680 |
| Keith Kucinski | Chief Financial Officer | $584,160 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Jerome Jabbour | CEO | $1,599,551 |
| Jerome D. Jabbour | Chief Executive Officer | $1,599,551 |
| James Ferguson | Former Chief Medical Officer | $880,603 |
| Keith Kucinski | Chief Financial Officer | $808,347 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Jerome Jabbour | CEO | $1,674,207 |
| Jerome D. Jabbour | Chief Executive Officer | $1,674,207 |
| James Ferguson | Chief Medical Officer | $869,099 |
| Theresa Matkovits | Chief Development Officer | $850,179 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Jerome D. Jabbour | Chief Executive Officer | $3,693,314 |
| Jerome Jabbour | CEO | $3,693,314 |
| James Ferguson | Chief Medical Officer | $1,621,937 |
| Theresa Matkovits | Chief Development Officer | $1,338,161 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Jerome Jabbour | CEO | $2,930,085 |
| Jerome D. Jabbour | Chief Executive Officer | $2,930,085 |
| James Ferguson | Chief Medical Officer | $1,650,043 |
| Theresa Matkovits | Chief Development Officer | $1,253,030 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Jerome D. Jabbour | Chief Executive Officer | $1,325,176 |
| Jerome Jabbour | CEO | $1,325,176 |
| James Ferguson | Chief Medical Officer | $752,315 |
| Theresa Matkovits | Chief Development Officer | $698,138 |
| Keith Kucinski | Chief Financial Officer | $626,595 |
| Roelof Rongen | Former Chief Executive Officer | $183,333 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Jerome D. Jabbour | Chief Executive Officer | $1,254,727 |
| Jerome Jabbour | CEO | $1,254,727 |
| Roelof Rongen | Former Chief Executive Officer | $400,000 |
| Theresa Matkovits | Chief Development Officer | $306,300 |
| Keith Kucinski | Chief Financial Officer | — |
| James Ferguson | Chief Medical Officer | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Robin L. Smith | Board | Resigned | 2026-07-13 |
| Jerome D. Jabbour | interim Chief Financial Officer | Appointed | 2026-01-23 |
| Keith Kucinski | Chief Financial Officer | Resigned | 2026-01-23 |
| Keith Kucinski | Chief Financial Officer | Resigned | 2025-11-21 |
Key facts
CIK
1582554
CUSIP
576810303
13F (30d)
15 filings
15 filers
Visit website
Investor relations